We are live on ! Find out more
SCM

Scopia Capital Management Portfolio holdings

AUM $146M
1-Year Est. Return 25.93%
This Fund
S&P 500
This Quarter Est. Return
-3.5%
1 Year Est. Return
+25.93%
3 Year Est. Return
+30.87%
5 Year Est. Return
+45.28%
10 Year Est. Return
+379.83%
AUM
$4.84B
AUM Growth
-$520M
Cap. Flow
-$271M
Cap. Flow %
-5.6%
Top 10 Hldgs %
58.98%
Holding
50
New
9
Increased
13
Reduced
15
Closed
7

Sector Composition

Rank Sector Weight
1 Healthcare 28.8%
2 Industrials 18.84%
3 Technology 16.24%
4 Communication Services 10.9%
5 Real Estate 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPR
1
DELISTED
Spirit AeroSystems
SPR
$549M 11.34%
12,772,652
-1,338,250
-9% -$61.6M
UTHR icon
2
United Therapeutics
UTHR
$26.1B
$456M 9.41%
4,301,352
+82,071
+2% +$9.15M
FCE.A
3
DELISTED
Forest City Realty Trust, Inc.
FCE.A
$401M 8.29%
17,987,140
-526,048
-3% -$11.5M
BIDU icon
4
Baidu
BIDU
$35.7B
$355M 7.33%
2,149,550
-199,427
-8% -$35M
ITRI icon
5
Itron
ITRI
$4.54B
$193M 3.98%
4,475,084
+1
+0% +$42
SABR icon
6
Sabre
SABR
$716M
$184M 3.79%
6,857,699
+714,102
+12% +$20.1M
JD icon
7
JD.com
JD
$43.5B
$182M 3.75%
8,553,118
+2,817,862
+49% +$68.1M
IWM icon
8
PUT
iShares Russell 2000 ETF
IWM
$79.1B
$180M 3.71%
1,563,300
-188,100
-11% -$21.2M
DST
9
DELISTED
DST Systems Inc.
DST
$179M 3.7%
3,081,958
+88,648
+3% +$5.2M
PRGO icon
10
Perrigo
PRGO
$1.44B
$178M 3.67%
1,961,477
+1,698,717
+646% +$176M
NFLX icon
11
Netflix
NFLX
$307B
$173M 3.57%
18,880,860
+416,880
+2% +$4M
MYGN icon
12
Myriad Genetics
MYGN
$476M
$142M 2.94%
4,654,327
-749,335
-14% -$26M
FICO icon
13
Fair Isaac
FICO
$31.8B
$136M 2.81%
1,202,599
+25,742
+2% +$2.79M
GWPH
14
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$135M 2.79%
+1,477,709
New +$124M
CNMD icon
15
CONMED
CNMD
$1.3B
$132M 2.73%
2,774,045
+393,781
+17% +$16.7M
SPY icon
16
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$129M 2.67%
616,200
-706,400
-53% -$147M
TMX
17
DELISTED
Terminix Global Holdings, Inc.
TMX
$122M 2.52%
+4,585,633
New +$117M
INSY
18
DELISTED
Insys Therapeutics, Inc.
INSY
$116M 2.4%
8,987,313
+75,241
+0.8% +$1.1M
JCI icon
19
Johnson Controls International
JCI
$85.1B
$113M 2.34%
+2,448,163
New +$108M
IBKR icon
20
Interactive Brokers
IBKR
$38.4B
$99.3M 2.05%
11,216,808
-2,933,852
-21% -$28M
ZBRA icon
21
Zebra Technologies
ZBRA
$13.5B
$94.7M 1.95%
+1,889,480
New +$110M
ACOR
22
DELISTED
Acorda Therapeutics
ACOR
$80.9M 1.67%
26,427
+4,298
+19% +$14M
TVTX icon
23
Travere Therapeutics
TVTX
$5.17B
$67.9M 1.4%
3,811,821
+213,599
+6% +$3.46M
WMB icon
24
Williams Companies
WMB
$85.8B
$58.4M 1.21%
+2,699,540
New +$54.2M
NDRM
25
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$55M 1.14%
3,383,358
-1
-0% -$17

Similar funds

Scopia Capital Management's Q2 2016 Portfolio in Review

As of Q2 2016, Scopia Capital Management held 50 positions worth $4.84B, down 9.7% from $5.36B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Scopia Capital Management withdrew a net $271M in Q2 2016, closing 7 positions and reducing 15 holdings. Its most notable exit was Huntsman Corp, an estimated $197M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 22% a quarter earlier, followed by Industrials and Technology.

Against the trend, Scopia Capital Management opened a new position in GW Pharmaceuticals Plc American Depositary Shares worth $135M.

  • Scopia Capital Management's largest Q2 2016 buy was GW Pharmaceuticals Plc American Depositary Shares: 1,477,709 shares worth $135M.
  • Scopia Capital Management added most to Perrigo in Q2 2016, an estimated $176M increase.
  • Scopia Capital Management's biggest Q2 2016 reduction was Melco Resorts & Entertainment, cutting an estimated $135M.
  • Scopia Capital Management fully exited Huntsman Corp in Q2 2016, selling an estimated $197M.
  • Scopia Capital Management's ten largest holdings make up 59% of its $4.84B portfolio in Q2 2016.
  • Scopia Capital Management opened 9 new positions and closed 7 in Q2 2016.
  • Scopia Capital Management's portfolio value fell 9.7% quarter-over-quarter to $4.84B.

Based on Scopia Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.